DexCom's growth rate has been improving, but that hasn't been enough of a reason for investors to buy up the stock.

Weeks after launching its first open call for diabetes advocates, Dexcom is spotlighting the resulting group of 16 people in ...

Dexcom has issued a Class I recall for its G6 Android app due to crashes that could cause users to miss critical glucose ...

Although DexCom stock has trailed the broader market over the past year, analysts remain bullish about its prospects.

DexCom, Inc. DXCM is well-poised for growth in the coming quarters, backed by a huge potential in the CGM market. A strong third-quarter 2025 performance and a series of favorable coverage decisions ...

However, the company's financial results have been pretty strong. And if DexCom can keep that up in its next quarterly update ...

SAN DIEGO--(BUSINESS WIRE)-- DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today that Stelo, the first over-the-counter ...

A software defect could cause the app to terminate, resulting in missed alerts or alarms. Dexcom required users to update the ...

Now, it’s worth noting Stock Advisor’s total average return is 1,055% — a market-crushing outperformance compared to 194 % ...

SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its third quarter 2024 financial results after market close on Thursday, October 24, 2024. Management ...

Dexcom has been hit by a major safety issue for an Android version of its G6 continuous monitoring system app, leading the FDA to issue its most serious recall notice. | Dexcom has been hit by a major ...

The DJS Law Group reminds investors of a class action lawsuit against DexCom, Inc. ("DexCom" or "the Company") (NASDAQ: DXCM) for violations of §§10 (b) and 20 (a) of the Securities Exchange Act of ...